Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC564017143;17144;17145 chr2:178731957;178731956;178731955chr2:179596684;179596683;179596682
N2AB532316192;16193;16194 chr2:178731957;178731956;178731955chr2:179596684;179596683;179596682
N2A439613411;13412;13413 chr2:178731957;178731956;178731955chr2:179596684;179596683;179596682
N2BNoneNone chr2:Nonechr2:None
Novex-1NoneNone chr2:Nonechr2:None
Novex-2NoneNone chr2:Nonechr2:None
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: T
  • RefSeq wild type transcript codon: ACC
  • RefSeq wild type template codon: TGG
  • Domain: Ig-40
  • Domain position: 4
  • Structural Position: 4
  • Q(SASA): 0.4147
  • Predicted PPI site: I

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
T/S rs2080609627 None None N 0.075 0.116 0.124217242631 gnomAD-4.0.0 5.50119E-06 None None None None I None 0 0 None 0 0 None 0 0 7.23117E-06 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
T/A 0.075 likely_benign 0.0802 benign -0.841 Destabilizing 0.008 N 0.145 neutral N 0.504925141 None None I
T/C 0.2785 likely_benign 0.309 benign -0.43 Destabilizing 0.001 N 0.183 neutral None None None None I
T/D 0.283 likely_benign 0.3061 benign -0.009 Destabilizing 0.22 N 0.289 neutral None None None None I
T/E 0.175 likely_benign 0.1909 benign 0.03 Stabilizing 0.055 N 0.302 neutral None None None None I
T/F 0.1678 likely_benign 0.1878 benign -0.777 Destabilizing 0.497 N 0.484 neutral None None None None I
T/G 0.1934 likely_benign 0.2057 benign -1.127 Destabilizing 0.055 N 0.227 neutral None None None None I
T/H 0.1733 likely_benign 0.1928 benign -1.195 Destabilizing 0.667 D 0.372 neutral None None None None I
T/I 0.0913 likely_benign 0.104 benign -0.156 Destabilizing 0.042 N 0.279 neutral N 0.439988228 None None I
T/K 0.1138 likely_benign 0.1275 benign -0.61 Destabilizing None N 0.113 neutral None None None None I
T/L 0.0671 likely_benign 0.0705 benign -0.156 Destabilizing None N 0.111 neutral None None None None I
T/M 0.074 likely_benign 0.0805 benign -0.072 Destabilizing 0.497 N 0.317 neutral None None None None I
T/N 0.1075 likely_benign 0.1146 benign -0.63 Destabilizing 0.096 N 0.113 neutral N 0.505618574 None None I
T/P 0.1223 likely_benign 0.1405 benign -0.352 Destabilizing 0.301 N 0.329 neutral N 0.455415852 None None I
T/Q 0.1318 likely_benign 0.1454 benign -0.677 Destabilizing 0.22 N 0.329 neutral None None None None I
T/R 0.085 likely_benign 0.0967 benign -0.407 Destabilizing 0.004 N 0.182 neutral None None None None I
T/S 0.091 likely_benign 0.0941 benign -0.952 Destabilizing None N 0.075 neutral N 0.47933605 None None I
T/V 0.0905 likely_benign 0.0978 benign -0.352 Destabilizing None N 0.058 neutral None None None None I
T/W 0.3942 ambiguous 0.4302 ambiguous -0.76 Destabilizing 0.958 D 0.372 neutral None None None None I
T/Y 0.1882 likely_benign 0.2042 benign -0.516 Destabilizing 0.667 D 0.491 neutral None None None None I

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.